Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ News / India/  Centre fixes retail prices of diabetes, high blood pressure, 74 other medicines. Check latest rates
BackBack

Centre fixes retail prices of diabetes, high blood pressure, 74 other medicines. Check latest rates

The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country.

NPPA fixes prices of medicines (REUTERS)Premium
NPPA fixes prices of medicines (REUTERS)

The government's National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 74 medicines including diabetes, high blood pressure, etc.

NPPA has fixed the prices of drugs under the Drugs (Prices Control) Order 2013 based on the decision taken in the 109th meeting of the Authority held on 21 February.

As per the notification by the NPPA, the cost of one tablet of Dapagliflozin Sitagliptin and Metformin Hydrochloride (Extended-Release Tablet) has been fixed at 27.75.

Similarly, the drug regulatory body has also reduced prices of blood pressure medicine such as telmisartan (used to treat high blood pressure, heart failure, and diabetic kidney disease) and bisoprolol fumarate (used for heart disease). The cost of one tablet has been reduced to 10.92.

The NPPA has also revised the ceiling prices of 80 notified drugs (NLEM 2022), including those used in the treatment of epilepsy and neutropenia.

Besides, the NPPA has also reduced the prices of Sodium Valproate (20mg). The price of one tablet has been fixed at 3.20. Apart from this, the price of Filgrastim injection (one vial) has been fixed at 1,034.51.

Apart from this, the price of Hydrocortisone, which is a steroid, has been changed to 13.28 per tablet.

The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels. The regulator implements and enforces the provisions of the Drugs (Prices Control) Order. It is also entrusted with the task of recovering amounts overcharged by manufacturers for controlled drugs from consumers.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 28 Feb 2023, 10:17 AM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App